PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 19, 2009, Pages 7852-7857

  Yoon, Cheol Hee ^a   Lee, Eun Soo ^a   Lim, Dae Seog ^b   Bae, Yong Soo ^a,b  

^a Sungkyunkwan University   (South Korea)

^b CreaGene Research Institute   (South Korea)

Author keywords

p53 tumor suppression; p53RE; Translation inhibition and apoptosis

Indexed keywords

CIS ACTING ELEMENT; DNA; INITIATION FACTOR 2ALPHA; INTERFERON; PROTEIN KINASE R; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DNA DAMAGE; GENE FUNCTION; GENE TARGETING; GENOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRESS; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA DAMAGE; EIF-2 KINASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; MUTAGENS; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EUKARYOTA; MUS MUSCULUS;

EID: 66049147774     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0812148106     Document Type: Article

References (35)

1. Agami R, Bernards R (2000) Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102(1):55-66.
2. Bensaad K, et al. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126(1):107-120. (Pubitemid 44040989)
3. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88(3):323-331. (Pubitemid 27131374)
4. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408(6810):307-310.
5. Sherr CJ (2004) Principles of tumor suppression. Cell 116(2):235-246. (Pubitemid 38167315)
6. el-Deiry WS (2003) The role of p53 in chemosensitivity and radiosensitivity. Oncogene 22(47):7486-7495.
7. Villunger A, et al. (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302(5647):1036-1038. (Pubitemid 37386194)
8. el-Deiry WS, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75(4):817-825.
9. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20(15):1803-1815. (Pubitemid 32458690)
10. Sax JK, El-Deiry WS (2003) p53 downstream targets and chemosensitivity. Cell Death Differ 10(4):413-417. (Pubitemid 36626353)
11. Crighton D, et al. (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126(1):121-134. (Pubitemid 44040988)
12. Cui R, et al. (2007) Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128(5):853-864. (Pubitemid 46341415)
13. Biron CA (2001) Interferons alpha and beta as immune regulators - a new look. Immunity 14(6):661-664. (Pubitemid 32592413)
14. Zamanian-Daryoush M, Der SD, Williams BR (1999) Cell cycle regulation of the double stranded RNA activated protein kinase, PKR. Oncogene 18(2):315-326. (Pubitemid 29060607)
15. Balkwill FR, Smyth JF (1987) Interferons in cancer therapy: A reappraisal. Lancet 2(8554):317-319.
16. Takaoka A, et al. (2003) Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424(6948):516-523. (Pubitemid 36975769)
17. Kuhen KL, Samuel CE (1997) Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5′-flanking region of human and mouse Pkr genes. Virology 227(1):119-130. (Pubitemid 27241061)
18. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM (1999) Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285(5424):107-110. (Pubitemid 29307576)
19. Baltzis D, et al. (2007) The eIF2alpha kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53. J Biol Chem 282(43):31675-31687. (Pubitemid 350044850)
20. Marques JT, et al. (2005) Down-regulation of p53 by double-stranded RNA modulates the antiviral response. J Virol 79(17):11105-11114. (Pubitemid 41170651)
21. Komarov PG, et al. (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285(5434):1733-1737. (Pubitemid 29428873)
22. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (1992) Definition of a consensus binding site for p53. Nat Genet 1(1):45-49.
23. Lu J, O'Hara EB, Trieselmann BA, Romano PR, Dever TE (1999) The interferon-induced double-stranded RNA-activated protein kinase PKR will phosphorylate serine, threonine, or tyrosine at residue 51 in eukaryotic initiation factor 2alpha. J Biol Chem 274(45):32198-32203. (Pubitemid 129503817)
24. Yang Q, Guan KL (2007) Expanding mTOR signaling. Cell Research 17(8):666-681. (Pubitemid 47255937)
25. Feng Z, Zhang H, Levine AJ, Jin S (2005) The coordinate regulation of the p53 andmTOR pathways in cells. Proc Natl Acad Sci USA 102(23):8204-8209. (Pubitemid 40800067)
26. Akhtar RS, et al. (2006) BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death. J Neurosci 26(27):7257-7264.
27. Jiang HY, Wek RC (2005) Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J Biol Chem 280(14):14189-14202. (Pubitemid 40517321)
28. Lee E, Yoon C, Kim Y, Bae Y (2007) The double-strand RNA-dependent protein kinase PKR plays a significant role in a sustained ER stress-induced apoptosis. FEBS Lett 581(22):4325-4332. (Pubitemid 47301867)
29. Mantena SK, Sharma SD, Katiyar SK (2006) Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 27(10):2018-2027. (Pubitemid 44530576)
30. WeiCL, et al. (2006)A global map of p53 transcription-factor binding sites in the human genome. Cell 124(1):207-219. (Pubitemid 43069320)
31. Green DR, Chipuk JE (2006) p53 and metabolism: Inside the TIGAR. Cell 126(1):30-32.
32. Tanaka T, Ohkubo S, Tatsuno I, Prives C (2007) hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell 130(4):638-650. (Pubitemid 47268061)
33. Resnick-Silverman L, St Clair S, Maurer M, Zhao K, Manfredi JJ (1998) Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev 12(14):2102-2107. (Pubitemid 28348033)
34. Munoz-Fontela C, et al. (2008) Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med 205(8):1929-1938.
35. Tilleray V, Constantinou C, Clemens MJ (2006) Regulation of protein synthesis by inducible wild-type p53 in human lung carcinoma cells. FEBS Lett 580(7):1766-1770.